TDMR Europe holds successful interactive event and highlights TDR’s impact on obesity

Experts debunk myths about weight loss with TDR and show its effectiveness in reducing obesity and overweight.

In a webinar organized by TDMR Europe on 14th April Professor Anthony Leeds (TDMR Europe Chair), Dr George Thom (University of Glasgow), Dr Kelly Johnston (King’s College London) and Mark Gilbert (TDMR Europe Science Committee) highlighted how Total Diet Replacement (TDR) can be an effective solution to tackling alarming obesity and overweight rates in Europe. The on-line seminar titled “Proven Facts versus Popular Myth about weight loss with Total Diet Replacement” focussed on debunking common popular myths about weight loss and presented the potential benefits of using TDR for weight loss.

Professor Anthony Leeds, Chairman of TDMR Europe, said:

It is time for policymakers to acknowledge that obesity prevention strategies aiming to change consumers’ food behaviours are not enough. They need to focus on providing solutions for people with obesity. TDRs can be instrumental in the efforts to bring down the incidence of obesity and overweight.”

Sharing updates on the latest research on TDR Prof Leeds highlighted its impact on type 2 diabetes, stressing that “TDR programmes deliver, in a short period of time, the amounts of weight loss needed to achieve major health improvements such as type 2 diabetes prevention and remission and other obesity related diseases”.

Although several recent large-scale trials have demonstrated that TDR-led interventions can induce initial average weight losses of 10-15% body weight, Dr Thom cautioned that “preventing weight regain over the longer-term remains the major challenge”. Focusing on physiological and behavioural factors involved in weight loss maintenance, Dr Thom said that “some degree of weight regain is normal for a variety of reasons, and conveying this message sensitively to people seeking to maintain weight can not only reduce shame and blame, but facilitate pro-active relapse management.” Dr Thom also provided interesting suggestions on how practitioners may support individuals living with obesity to improve weight loss maintenance. He argued that “there is no single mechanism to explain weight loss maintenance. Yet, increases in appetite and adaptive reductions in energy expenditure may undermine self-regulation of eating and long-term behaviour change”.

An insightful discussion on misinformation and myths on TDR followed, with Dr Johnston pointing out the urgency of addressing these myths as “they slow the acceptance of what could be a powerful ally in tackling obesity”. Dr Johnston argued that false beliefs about TDR are widespread and ultimately affect the public health’s effort to fight obesity as well as the allocation of research resources on this issue. “There is a huge amount of misinformation about TDR in the public domain, with some of it coming from those very organisations and professionals who should be helping educate consumers as to benefits of this very well evidenced, safe solution. As a matter of priority, and so that this effective obesity treatment becomes more widely, this must be addressed” Dr Johnston said.

Mr Gilbert from TDMR Europe Science Committee also said that there is an “undeserved negative mythology surrounding TDR”. Discussing proven facts on weight loss with TDR, Mr Gilbert argued that “rapid, substantial weight loss with TDR does not increase the proportion of lean body mass losses when compared to moderate weight loss, and muscle quality is not compromised”.

 

World Health Day, 7 April 2021 – Universal Health Coverage: everyone, everywhere

TDMR Europe welcomes the World Health Organisation’s ‘World Health Day’ that commemorates the founding of WHO in 1948.  This year the theme reflects the disparities in healthcare available to different groups across the globe, brought into sharp focus by the COVID19 crisis, and reflects a desire to make healthcare truly universal.

Recognising that the burden of suffering of type 2 diabetes mellitus (T2DM) and related health-care costs will rise disproportionately in low and middle-income countries, TDMR Europe notes that effective prevention and early T2DM remission ought to be a part of any national healthcare programme.  Several T2DM prevention programmes show that weight reduction is the most important component of T2DM prevention, along with increased physical activity and optimal composition of the maintenance diet.  The more weight that can be lost the greater the reduction in numbers of people developing T2DM we can expect to see.  Despite this clear evidence, there are only a few T2DM prevention programmes that effectively deliver large weight losses (7-10% of body weight).  The PREVIEW diabetes prevention programme has shown that a large initial weight loss of an average 10% body weight with Total Diet Replacement (TDR) followed by a structured diet focussing on glycaemic index and higher protein content, delivered fewer cases of T2DM 3 years later than would have been expected.  The next practical challenge is to introduce PREVIEW-style initial weight loss with TDR and lower GI, lower glycaemic load and higher protein maintenance diet into the T2DM prevention programmes of many more countries.

Early T2DM remission programmes, that incorporate an initial large weight loss with TDR, could also be offered in more countries than is currently the case.  Within the UK, Scotland and England currently have such programmes in early stages, as does Abu Dhabi and Qatar in the middle East, and there are a small number of diabetes remission clinics in South East Asia.

However, there is clearly much more to do. In addition to generating first class clinical trial evidence there is a need to share knowledge and experience in the use of TDR weight loss followed by effective weight maintenance.  To this end TDMR chairman, Professor Anthony Leeds recently spoke to Professor Mike Lean, principal investigator of the DiRECT diabetes remission trial, in two programmes on the EAWAZ TV channel.

Introducing the programmes Professor Leeds said ‘I am greatly encouraged by the interest shown globally in this type of intervention especially in parts of the world with very high rates for obesity and T2DM, such as Malaysia and the Arabian Gulf States. I am glad that Prof Shahrad Taheri has conducted the DIADEM-1 study in Qatar demonstrating that people of Middle Eastern and North African origin were able to successfully follow TDR weight loss and maintenance and go into T2DM remission in many cases. The stage is set for weight loss with TDR followed by structured weight maintenance programmes to help address this global challenge.’

 

Watch the interviews with Professor Mike Lean at:  https://youtu.be/4WKd8sB5nhs  and https://youtu.be/qcjgFU2jhDA

For further information on diabetes remission and the DiRECT trial see:

https://www.diabetes.org.uk/guide-to-diabetes/managing-your-diabetes/treating-your-diabetes/type2-diabetes-remission

https://www.diabetes.org.uk/research/research-round-up/research-spotlight/research-spotlight-low

https://www.diabetes.org.uk/guide-to-diabetes/enjoy-food/eating-with-diabetes/whats-your-healthy-weight/low-calorie-diets

For a diabetes risk calculator go to: https://riskscore.diabetes.org.uk/start

For more details and references on the PREVIEW study go to: https://tdmr-europe.com/2020/11/25/prevention-of-diabetes-through-lifestyle-intervention-in-europe-and-australasia-preview/

For more details on the DiRECT study go to:  https://tdmr-europe.com/2020/08/04/reducing-future-risk-obesity-co-morbidities-and-nutritional-status-mike-lean/

For more details on the DIADEM-1 study go to: https://tdmr-europe.com/2020/05/22/intensive-life-style-intervention-including-initial-weight-loss-with-tdr-delivered-60-diabetes-remission-in-people-with-early-type-2-diabetes-mellitus-from-the-middle-east-and-north-africa-studied-i/